Identification of unique gene expression patterns within different lesional sites of keloids

Wound Repair and Regeneration

Volumn 16, Issue 2, 2008, Pages 254-265

  Seifert, Oliver ^a   Bayat, Ardeshir ^b   Geffers, Robert ^c   Dienus, Kirstin ^e   Buer, Jan ^d   Löfgren, Sture ^e   Matussek, Andreas ^e  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; PROTEOGLYCAN; STROMELYSIN;

ADULT; APOPTOSIS; ARTICLE; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; KELOID; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; UNINDEXED SEQUENCE; UPREGULATION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KELOID; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 40349093374     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2007.00343.x     Document Type: Article

References (38)

1. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998 4 : 19 24.
2. Bock O, Mrowietz U. Keloids. A fibroproliferative disorder of unknown etiology. Hautarzt 2002 53 : 515 23.
3. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001 137 : 1429 34.
4. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975 67 : 428 32.
5. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990 43 : 70 7.
6. Haverstock BD. Hypertrophic scars and keloids. Clin Podiatr Med Surg 2001 18 : 147 59.
7. Marneros AG, Krieg T. Keloids - clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges 2004 2 : 905 13.
8. Satish L, Lyons-Weiler J, Hebda PA, Wells A. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen 2006 14 : 463 70.
9. Chen W, Fu X, Sun X, Sun T, Zhao Z, Sheng Z. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res 2003 113 : 208 16.
10. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002 55 : 283 6.
11. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 111 : 535 43 discussion 44-6.
12. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004 13 : 120 4.
13. Bayat A, Walter JM, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005 58 : 914 21.
14. Matussek A, Lauber J, Bergau A, Hansen W, Rohde M, Dittmar KE, Gunzer M, Mengel M, Gatzlaff P, Hartmann M, Buer J, Gunzer F. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 2003 102 : 1323 32.
15. Kawaguchi N, Sundberg C, Kveiborg M, Moghadaszadeh B, Asmar M, Dietrich N, Thodeti CK, Nielsen FC, Möller P, Mercurio AM, Albrechtsen R, Wewer UM. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J Cell Sci 2003 116 : 3893 904.
16. Kveiborg M, Frohlich C, Albrechtsen R, Tischler V, Dietrich N, Holck P, Kronqvist P, Rank F, Mercurio AM, Wewer UM. A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res 2005 65 : 4754 61.
17. Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, Wali A, Fontana JA, Levi E, Majumdar AP. Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. J Biol Chem 2006 281 : 13188 98.
18. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M. Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). Life Sci 2000 66 : PL265 70.
19. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001 133 : 217 28.
20. Murphy G, Knauper V, Cowell S, Hembry R, Stanton H, Butler G, Freíje J, Pendáo AM, López-Otín C. Evaluation of some newer matrix metalloproteinases. Ann NY Acad Sci 1999 878 : 25 39.
21. Pilcher BK, Wang M, Qin XJ, Parks WC, Senior RM, Welguo HG. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann NY Acad Sci 1999 878 : 12 24.
22. Kuroda K, Utani A, Hamasaki Y, Shinkai H. Up-regulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts. J Dermatol Sci 2001 26 : 156 60.
23. Akita S, Daian T, Ishihara H, Fujii T, Akino K. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production. J Dermatol Sci 2004 36 : 11 23.
24. Figueroa B Jr., Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnol Bioeng 2004 85 : 589 600.
25. Chau BN, Cheng EH, Kerr DA, Hardwick JM. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 2000 6 : 31 40.
26. Shen X, Falzon M. PTH-related protein enhances LoVo colon cancer cell proliferation, adhesion, and integrin expression. Regul Pept 2005 125 : 17 27.
27. Fietta A, Bardoni A, Salvini R, Passadore I, Morosini M, Cavagna L, Codullo V, Pozzi E, Meloni F, Montecucco C. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther 2006 8 : R160.
28. Chen WT, Kelly T. Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 2003 22 : 259 69.
29. Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (London) 2005 108 : 277 92.
30. Mukhopadhyay A, Chan SY, Lim IJ, Phillips DJ, Phan TT. The role of the activin system in keloid pathogenesis. Am J Physiol Cell Physiol 2007 292 : C1331 8.
31. Tuan TL, Wu H, Huang EY, Chong SS, Laug W, Messadi D, Kelly P, Le A. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003 162 : 1579 89.
32. Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, Magaud JP, Rimokh R. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 2002 21 : 2227 35.
33. Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guidicci S, Landthaler M, Schölmerich J, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Müller-Ladner U. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 2001 44 : 2665 78.
34. Hartl D, Griese M, Nicolai T, Zissel G, Prell C, Reinhardt D, Schendel DJ, Krauss-Etschmann S. A role for MCP-1/CCR2 in interstitial lung disease in children. Respir Res 2005 6 : 93.
35. Napoleone E, di Santo A, Peri G, Mantovani A, de Gaetano G, Donati MB, Lorenzet R. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol 2004 76 : 203 9.
36. Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004 104 : 92 9.
37. Bornstein P, Kyriakides TR, Yang Z, Armstrong LC, Birk DE. Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis. J Investig Dermatol Symp Proc 2000 5 : 61 6.
38. Chen BK, Leiferman KM, Pittelkow MR, Overgaard MT, Oxvig C, Conover CA. Localization and regulation of pregnancy-associated plasma protein a expression in healing human skin. J Clin Endocrinol Metab 2003 88 : 4465 71.